Sowell Financial Services’s Cardiff Oncology CRDF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-200
Closed -$4K 3136
2020
Q4
$4K Hold
200
﹤0.01% 2321
2020
Q3
$3K Sell
200
-800
-80% -$5.28K ﹤0.01% 2112
2020
Q2
$5K Buy
+1,000
New +$2.05K ﹤0.01% 1885

Other funds holding CRDF

Sowell Financial Services's CRDF Position: Q1 2021 in Review

Sowell Financial Services sold out of Cardiff Oncology (CRDF) in Q1 2021, closing a stake of 200 shares — an estimated $4K sold.

Sowell Financial Services first reported a position in CRDF in Q2 2020 and held it in 3 quarters. The position peaked at $5K in Q2 2020. 73 funds tracked by Wall St. Rank hold CRDF as of Q1 2021.

  • Sowell Financial Services reported no remaining Cardiff Oncology position as of Q1 2021 after selling out during the quarter.
  • Sowell Financial Services sold 200 Cardiff Oncology shares in Q1 2021, an estimated $4K.
  • Sowell Financial Services first reported a position in Cardiff Oncology in Q2 2020 and held it in 3 quarters.
  • Sowell Financial Services's Cardiff Oncology position peaked at $5K in Q2 2020.
  • 73 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2021.

Based on Sowell Financial Services's 13F filing for Q1 2021, filed 7 May 2021.